FDA Approves Conceive Plus Fertility Personal Lubricant for US Market Release Conceive Plus Fertility Lubricant Approved by the Federal Drug Administration For Trying To Conceive Couples in the United States.
CHICAGO, Nov. 15, 2013 /PRNewswire/ -- The Pew Research Center reports that in the year 2011, the birth rate in the United States slid by 8%. That kind of statistic would indicate getting pregnant isn't as easy as it used to be. However, pharmaceutical manufacturer SASMAR aims to be at the forefront of helping couples to start families. The FDA has officially approved their OTC sperm friendly fertility personal lubricant, Conceive Plus for sale in the US market.
Conceive Plus Fertility Personal Lubricant is the isotonic fertility-friendly personal lubricant that helps trying to conceive couples increase their chances of getting pregnant naturally. The patent pending Conceive Plus formula is pH balanced to mimic fertile fluids and semen, contains magnesium and calcium ions, which are also found naturally in the human body and essential to the process of fertilization. Published clinical studies strongly indicate lubricants such as KY, Durex, Astroglide and Replens, have a negative effect on sperm motility and sperm chromatin integrity, hindering the fertilization process and the chances of conception.
SASMAR has just received the required 510(k) Premarket Notification and is in the process of acquiring distributors for the US Market. Major retailers and distributers in the U.S have been seeking to offer the sperm friendly lubricant manufactured by SASMAR, the multi-national pharmaceutical manufacturer that focuses specifically on products related to fertility, family planning and female health. Conceive Plus is sold over-the-counter in more than 60 countries.
Conceive Plus fertility personal lubricant is sperm friendly and intended for penile and/or vaginal application. It moisturizes and lubricates, in order to enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication without harming the process of fertilization. Compatible with sperm, oocytes, and embryos, Conceive Plus can also be used in fertility interventions to facilitate entry of diagnostic and therapeutic devices into the vaginal cavity. Conceive Plus is FDA cleared to claim that it is safe for use by couples who are trying to conceive a baby naturally.
For more information visit www.conceiveplus.com or contact SASMAR to become a distributor.
This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.
SOURCE Conceive Plus